Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Unilever’s dollar sales in the spotlight when it releases Q3 results

The market does not have high expectations for the group’s performance in its own right, though forex will be under the magnifying glass.

Unilever Plc (LON:ULVR) will cut a familiar story on Thursday as the dollar earning consumer brands firm releases third quarter results.

The parent of Hellmann’s, Dove and Domestos makes just 10% of its sales in the UK and as such has been a notable Brexit winner.

Nonetheless, the market does not have high expectations for the group’s performance in its own right.

UBS analyst Nik Oliver, in a preview note, said it is likely to see slowing sales trends, particularly for European food and health and personal care products. “We expect Q3 to be a tough quarter,” he added.

Elsewhere, Kepler analyst Richard Withagen highlights that company-compiled consensus sees sales growth of 2.95%, though he has a 2.5% growth.

“For full-year 2016, we forecast underlying sales growth of 3.7% compared to consensus of 4.0%,” Withagen added.

“We expect the core operating margin to increase by 50bps to 15.3%, while consensus is at 15.2%.”

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK